We are live on ! Find out more
SLDB icon

Solid Biosciences
SLDB

58 hedge funds and large institutions have $119M invested in Solid Biosciences in 2018 Q1 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.11% more ownership

Funds ownership: 0% → 3.11% (+3.1%)

Holders
58
Holders Change
+58
Holders Change %
–
% of All Funds
1.33%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
58
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$75.2M
2
RCM
RA Capital Management
Massachusetts
+$60.5M
3
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$44.8M
4
BC
Boxer Capital
California
+$16.9M
5
CAM
Cormorant Asset Management
Massachusetts
+$15.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
1
JP Morgan Chase
New York
$25.1M +$75.2M +222,774 New
RCM
2
RA Capital Management
Massachusetts
$20.2M +$60.5M +179,296 New
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$14.9M +$44.8M +132,630 New
BC
4
Boxer Capital
California
$5.63M +$16.9M +50,000 New
CAM
5
Cormorant Asset Management
Massachusetts
$5.14M +$15.4M +45,731 New
BlackRock
6
BlackRock
New York
$4.79M +$14.4M +42,624 New
RI
7
RTW Investments
New York
$4.61M +$15.2M +45,051 New
BBA
8
Baker Bros. Advisors
New York
$4.41M +$13.2M +39,192 New
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$4.13M +$12.4M +36,667 New
EAM
10
Eventide Asset Management
Massachusetts
$3M +$9.01M +26,667 New
GTC
11
Ghost Tree Capital
New York
$2.89M +$8.67M +25,667 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$2.71M +$8.12M +24,037 New
Wellington Management Group
13
Wellington Management Group
Massachusetts
$2.33M +$6.99M +20,709 New
ACA
14
Avoro Capital Advisors
New York
$2.06M +$6.19M +18,333 New
Millennium Management
15
Millennium Management
New York
$2.02M +$6.07M +17,982 New
FCMI
16
Foresite Capital Management III
California
$2.02M +$7.61M +22,526 New
LCM
17
Laurion Capital Management
New York
$1.62M +$4.87M +14,413 New
Jennison Associates
18
Jennison Associates
New York
$1.32M +$3.98M +11,775 New
AG
19
Artal Group
Luxembourg
$1.13M +$3.38M +10,000 New
FCMI
20
Foresite Capital Management IV
California
$1.05M +$3.16M +9,355 New
RSCM
21
Rock Springs Capital Management
Maryland
$938K +$2.81M +8,333 New
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
$839K +$2.52M +7,457 New
State Street
23
State Street
Massachusetts
$713K +$2.14M +6,332 New
Northern Trust
24
Northern Trust
Illinois
$689K +$2.07M +6,118 New
HIM
25
Hillhouse Investment Management
Cayman Islands
$525K +$1.58M +4,667 New
1
2 3

SLDB Hedge Fund Activity: Q1 2018 in Review

58 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2018, worth a combined $119M.

Buyers outnumbered sellers: 58 funds opened new SLDB positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $75.2M.

  • 58 institutional investors held Solid Biosciences (SLDB) as of Q1 2018, up from 0 in Q4 2017.
  • Funds reported $119M of Solid Biosciences stock for Q1 2018.
  • 58 funds opened new Solid Biosciences positions in Q1 2018 and 0 closed out, a net change of +58 holders.
  • The largest Solid Biosciences buyer in Q1 2018 was JP Morgan Chase, an estimated $75.2M added.

Based on aggregated 13F filings for Q1 2018.